ID:T1452
PURITY:0.99
Formula:C22H18N4OS
MolWt:386.47
Appearance:白色粉末
Solubility:G4Soluble in DMSO
Bioactivity:Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3. Axitinib is marketed under the name Inlyta®, and if one previous systemic therapy for kidney cell cancer has failed, axitinib is indicated.
Status:USP,CP,
Pathways:Tyrosine Kinase/Adaptors
Target:c-Kit inhibitor; PDGFR inhibitor; VEGFR inhibitor
Receptor:c-Kit;PDGFRβ;VEGFR1, VEGFR2, VEGFR3
温馨提示:不可用于临床ZL。